EMMPRIN expression is associated with metastatic progression in osteosarcoma
Abstract Background Extracellular matrix metalloproteinase inducer (EMMPRIN), a cell-surface glycoprotein, is overexpressed in several cancer types. EMMPRIN induces a metastatic phenotype by triggering the production of matrix metalloproteinase proteins (MMPs) such as MMP1 and MMP2, and vascular end...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
BMC
2021-09-01
|
| Sarja: | BMC Cancer |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12885-021-08774-9 |